ALA-induced PpIX Fluorescence During Brain Tumor Resection

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

540

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Brain Tumors

Interventions

DRUG

5-aminolevulinic acid

Trial Locations (1)

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

David W. Roberts

OTHER